Entity monitoring profile
Central Admixture Pharmacy Services Verification and Monitoring Profile
Federal 503B registration status for Central Admixture Pharmacy Services, checked against the complete FDA register, with the open fields that remain.
Central Admixture Pharmacy Services appears on FDA's registered outsourcing facility list under two registered site entries: Central Admixture Pharmacy Services, Inc. (Allentown, PA), Central Admixture Pharmacy Services (Phoenix, AZ). Registration is a federal filing, not FDA approval, and not a finding of CGMP compliance. No inspection outcome, Form 483, warning letter, recall, or disciplinary record has been verified for this entity, so none is published.
Key findings
- Federal 503B registration: Registered 503B outsourcing facility.
- Two registered sites under the Central Admixture Pharmacy Services name.
- Registration means FDA received the required filing — it is not approval and not a CGMP finding.
- No inspection outcome, Form 483, warning letter, recall or disciplinary record is verified for this entity.
- Checked against the complete FDA register of 96 outsourcing facility registrations.
| Entity name as published | Central Admixture Pharmacy Services |
|---|---|
| Federal 503B registration | 503B Registration Verified Registered 503B outsourcing facility |
| Registered site(s) on FDA list |
|
| Registry checked against | 96 registrations, FDA list, 2026-07-23 |
| Operating model | Widely identified as a registered 503B outsourcing facility; registration to be confirmed against the current FDA list. |
| State licence and number | Verification Pending |
| Nonresident licences | Verification Pending |
| FDA inspection history | Verification Pending |
| Form 483 observations | Verification Pending |
| Warning letters | Verification Pending |
| Most recent action status | Verification Pending |
| Recalls (current) | Verification Pending |
| Recalls (historical) | Verification Pending |
| State disciplinary records | Verification Pending |
| Accreditations | Verification Pending |
| Ownership | Verification Pending |
Federal registration status
Two registered sites under the Central Admixture Pharmacy Services name.
Registration and inspections are facility specific. Facilities under common ownership and control are inspected individually. Before purchasing, FDA advises determining that the specific facility in which the drugs are compounded is an outsourcing facility with a satisfactory inspection. FDA
| Registered facility name | Location |
|---|---|
| Central Admixture Pharmacy Services, Inc. | Allentown, PA |
| Central Admixture Pharmacy Services | Phoenix, AZ |
What this means
- Central Admixture Pharmacy Services holds 2 registration entries on FDA's published list.
- The registered legal name and site location are stated as published by FDA.
- Registration and inspection are facility specific, so each site stands alone.
What this does not mean
- That this entity is compliant, safe, or non-compliant — none is asserted.
- That federal registration constitutes approval or a CGMP finding.
- That registration indicates a satisfactory inspection — FDA states it does not.
What can and cannot be established about Central Admixture Pharmacy Services today?
Verification of a compounding entity runs across two separate systems that do not talk to each other. The federal system covers outsourcing facilities only: registration, CGMP inspection, Form 483 observations, warning letters and recalls. The state system covers licensure, scope of permitted compounding, and discipline — and it is the only system that covers 503A pharmacies at all.
For Central Admixture Pharmacy Services, the federal side is settled at this snapshot: registered 503b outsourcing facility. The state side is not, and that is where the remaining evidentiary weight sits.
| Question | System that answers it | Status for this entity |
|---|---|---|
| Is it federally registered as a 503B facility? | FDA outsourcing facility register | 503B Registration Verified |
| Is its state pharmacy licence current? | State board of pharmacy | Verification Pending |
| Is it permitted to compound sterile preparations? | State board permit class | Verification Pending |
| Has FDA inspected it, and what was found? | FDA inspection records | Verification Pending |
| Are there Form 483 observations? | FDA inspection records | Verification Pending |
| Is there an active warning letter? | FDA warning letter database | Verification Pending |
| Any current or historical recalls? | FDA enforcement reports | Verification Pending |
| Any state disciplinary action? | State board orders | Verification Pending |
Why 2 separate entries matter
Central Admixture Pharmacy Services appears 2 times on the federal register because registration is per facility, not per company. Registration and inspections are facility specific. Facilities under common ownership and control are inspected individually. Before purchasing, FDA advises determining that the specific facility in which the drugs are compounded is an outsourcing facility with a satisfactory inspection. FDA
The practical consequence is that a finding at one site — an inspection outcome, a 483, a recall — describes that site and not the others. Reporting a company-level conclusion from a single-facility record is one of the most common errors in this sector, and this platform does not make it.
What a buyer should do with this record
This page settles one question and names the records that settle the rest. It is a starting point for verification, not a substitute for it.
If a programme names Central Admixture Pharmacy Services as its dispensing pharmacy, the next step is the state board register — that confirms whether the licence is current today, which no snapshot can. Then, if a 503B claim is made, confirm it against the FDA register directly rather than accepting the claim.
What remains open for Central Admixture Pharmacy Services
Central Admixture Pharmacy Services's federal register position is settled at this snapshot. What is not settled is everything held by state boards: the licence itself, its number and expiry, nonresident licensure, and any disciplinary record. Those sit with the board in each state where it operates.
To determine whether a registered outsourcing facility has been the subject of a state enforcement action, FDA directs the public to check with the State Board of Pharmacy for the state in which the facility is located. FDA
The method used for each field, and why none of it can be inferred, is set out on the methodology page. Sector-level context on the gap between registration and inspection is on the monitoring hub.
- Checked against FDA's register of 96 registrations on 2026-07-23; FDA updates the list weekly.
- Self-reported registration information on FDA's list has not been verified by FDA.
- State licensure, inspection outcomes and enforcement records have not been checked for this entity.
- Sector statistics describe the 503B population, not this entity.
Sources checked for this entity — 5 sources
- FDA Registered Outsourcing Facilities listchecked 2026-07-23
- FDA — Information for Outsourcing Facilitieschecked 2026-07-23
- FDA — Q&A: Outsourcing Facility Registrationchecked 2026-07-23
- FDA — Registered Outsourcing Facilitieschecked 2026-07-23
- FDA — Aligning Federal and State Regulation of Compounderschecked 2026-07-23
Related records in this section
Section hub: Pharmacy profiles · Methodology · Status definitions · Right to respond
Frequently asked questions
Is Central Admixture Pharmacy Services a registered 503B outsourcing facility?
Yes. It appears on FDA's register as Central Admixture Pharmacy Services, Inc. (Allentown, PA), Central Admixture Pharmacy Services (Phoenix, AZ).
How many registered sites does Central Admixture Pharmacy Services operate?
2 appear on the current list. FDA inspects facilities individually, so a record at one site does not describe another.
Does registration mean FDA approved Central Admixture Pharmacy Services?
No. Registration means FDA received the required filing and the annual establishment fee was paid. It is not approval and not a finding of CGMP compliance.
Has Central Admixture Pharmacy Services been inspected by FDA?
Not verified on this page. FDA publishes inspection dates and status on its register; sector-wide, a substantial share of newly registered facilities had not been inspected as of July 2025.
Can Central Admixture Pharmacy Services still compound semaglutide or tirzepatide?
Both shortages are resolved and FDA proposed on 30 April 2026 to exclude both from the 503B bulks list, restricting bulk compounding by outsourcing facilities. Narrow patient-specific 503A compounding may remain available. This page assesses no entity's compliance.
Does this page allege anything about Central Admixture Pharmacy Services?
No. It reports federal register status with its source and date, and lists what remains unverified. No violation, finding, or concern is asserted.
Sources
- FDA Registered Outsourcing Facilities list
- FDA — Information for Outsourcing Facilities
- FDA — Q&A: Outsourcing Facility Registration
- FDA — Registered Outsourcing Facilities
- FDA — Aligning Federal and State Regulation of Compounders
Update history
| Date | Change |
|---|---|
| 2026-07-23 | Record published at current snapshot. |
Dates change only for substantive updates. Entities may submit a correction or response through the right-to-respond process.